What's Fueling The High U.S. Death Rate? It Might Not Be What You Think
Medically reviewed by Drugs.com
via HealthDayTUESDAY, May 12, 2026 — The United States has a higher death rate than other wealthy nations — but not for the reason experts have suspected, a new study says.
Some have thought that an increase in substance-related deaths and suicide – so-called “deaths of despair” – has been boosting the U.S. death rate and causing life expectancy to sag.
But a couple of well-known reasons better explain why the United States lags other high-income nations in dying before one’s time, researchers reported May 8 in JAMA Network Open.
Heart disease and obesity-related health problems accounted for more than half (52%) of more than 900,000 excess deaths that occurred in the United States in 2022 compared to other wealthy countries, researchers found.
“Examining the stagnation in U.S. life expectancy that began in 2010 usually focuses on drug overdoses, alcohol-related deaths and suicide, known as ‘deaths of despair,’ ” said senior researcher Andrew Stokes, an associate professor of global health at Boston University.
”One dramatic finding from this study is that on an absolute scale, cardiometabolic diseases are key contributors to the increase in US death rates,” Stokes said in a news release. “If there was one thing we could address on a population scale, tackling cardiometabolic diseases would substantially reduce the US mortality gap with other wealthy nations.”
For the study, researchers analyzed more than 63.5 million deaths that occurred in the United States from 1999 to 2022, tracking their main causes and comparing them to rates in other wealthy nations.
Researchers estimated that of those deaths, nearly 12.7 million could have been avoided if the U.S. had rates of illness and death similar to those of its peer nations. Here's what else they found:
These heart-related deaths might be driven by a lack of preventive care when it comes to heart health in the United States, said Dr. Neil Shah, a cardiologist at Northwell Health in Great Neck, New York.
“We're seeing a lot of these patients when they're at a point where they've had downstream effects, whether that be coronary disease, any type of cardiovascular disease, heart failure, stroke, chronic kidney disease,” Shah said. “They're touching healthcare well beyond the point where prevention could have made a meaningful difference.”
He reflected, briefly, on what to do about it.
“In order to tackle this, I think as a country, from a policy standpoint, we need to figure out how we are going to get patients into preventive care and preventive screening, so that we can use the medications and the counseling that truly make a difference early on to prevent these later cardiovascular outcomes,” Shah said. “I think that's the most important step."
The study found that the United States did outperform other wealthy countries in a couple of categories, suffering fewer excess deaths in 2022 for cancers (excluding lung cancer) and influenza.
Stokes attributed this to advances in U.S. medicine.
“We’ve come a long way with medical innovations to screen and treat cancers,” he said.
At the same time, the United States cannot afford to overlook the dramatic increase in deaths of despair, given that combined they contributed to 18% of excess deaths, said Dr. Xavier Jimenez, director of consultation psychiatry, addiction medicine and chronic pain at Northwell Long Island Jewish Medical Center in Queens, New York.
“... Behavioral health concerns that go unaddressed catch up with individuals and contribute to an enormous slice of mortality via overdoses, impulsive behaviors, suicide, violence, accidents,” he said.
"COVID-19 really only jet fueled the despair that was already being experienced even before that pandemic," Jimenez added. "If you remember, we had opioid crises, we had political shifts, economic recessions, and then COVID-19 came and isolated individuals, reduced access to care, created enormous burdens and stress, not to mention the physical effects of COVID-19."
He said "it only makes sense" that during and right after the pandemic, COVID was contributing to the despair that was already being felt and accelerated by these processes.
"It even shaped a whole generation of younger adults now who are still dealing with the ramifications of COVID-19," Jimenez added.
Sources
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2026-05-12 21:15
Read more
- Adding Weekly GLP-1 to Cognitive Behavioral Therapy Further Reduces Heavy Drinking
- Pasithea Therapeutics Announces Grant of Rare Pediatric Disease Designation (RPDD) by FDA to PAS-004 for Treatment of Neurofibromatosis Type 1 (NF1)
- CMS Extends Medicare's Short-Term Bridge Program for GLP-1 Obesity Drug Coverage
- Class of Migraine Drug, CGRP Inhibitors, Has Added Benefit: Reduced Glaucoma Risk
- Johnson & Johnson Investigational Co-Antibody Therapy JNJ-4804 Shows Potential to Raise the Bar for Clinical Efficacy in Treating Refractory Inflammatory Bowel Disease
- Black Women Hit Hardest By Pandemic-Related Rise In Pregnancy-Related Deaths
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions